Serum tumour necrosis factor ‐α and interleukin‐6 levels in Alzheimer's disease and mild cognitive impairment

ConclusionsThe present study suggests that serum IL‐6 levels of patients with AD might be higher than those of subjects with MCI and healthy controls. Serum TNF‐α and IL‐6 levels might be negatively correlated with cognitive function, and we suspect that serum IL‐6 levels could be biomarkers for AD.

Source: Psychogeriatrics - January 27, 2017 Category: Geriatrics Authors: Yo Sup Kim, Kang Joon Lee, Hyun Kim Tags: Original Article Source Type: research